Frequency Therapeutics Inc (OQ:FREQ)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for FREQ within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 12/20 Arnold Wendy S Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 130,000  
Feb 14/20 Feb 12/20 Mitrano Richard J. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 18,000  
Feb 14/20 Feb 12/20 Loose Christopher R. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 57,500  
Feb 14/20 Feb 12/20 Hilt Dana Charles Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 50,000  
Feb 14/20 Feb 12/20 Lucchino David L. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 242,500  
Feb 14/20 Feb 12/20 LeBel Carl Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 57,500  
Feb 3/20 Jan 30/20 Cohen Marc A Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -21,827  
Feb 3/20 Jan 30/20 Cohen Marc A Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -16,691  
Feb 3/20 Jan 30/20 Cohen Marc A Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -8,042  
Feb 3/20 Jan 30/20 Cohen Marc A Indirect Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,778 $3.37
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for FREQ within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 12/20 Arnold Wendy S Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 130,000  
Feb 14/20 Feb 12/20 Mitrano Richard J. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 18,000  
Feb 14/20 Feb 12/20 Loose Christopher R. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 57,500  
Feb 14/20 Feb 12/20 Hilt Dana Charles Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 50,000  
Feb 14/20 Feb 12/20 Lucchino David L. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 242,500  
Feb 14/20 Feb 12/20 LeBel Carl Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 57,500  
Feb 3/20 Jan 30/20 Cohen Marc A Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -21,827  
Feb 3/20 Jan 30/20 Cohen Marc A Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -16,691  
Feb 3/20 Jan 30/20 Cohen Marc A Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -8,042  
Feb 3/20 Jan 30/20 Cohen Marc A Indirect Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,778 $3.37
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $FREQ

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Vir Biotechnology (OQ:VIR)
Alnylam Pharmaceuticals (OQ:ALNY)